Summary of NICE advice on OA assessment and treatment.
Apremilast (Otezla) has been approved by NICE for treating psoriatic arthritis.
The prescribing information for apremilast (Otezla) has been updated with warnings relating to suicidal ideation and behaviour.
The recommended dose of Arcoxia (etoricoxib) has been reduced to 60mg daily for patients with rheumatoid arthritis or ankylosing spondylitis.
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
Register or Subscribe to MIMSGPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.
MIMS bulletinsNews and updates straight to your inbox.
Prescribing Update: Fortnightly news bulletin
Alert: Urgent prescribing updates
Spotlight: Disease-themed monthly round-up
Read the latest issue online exclusively on MIMS Learning.
Handy calculators and conversions for primary care.